Fluid Therapy



Fluid Therapy


Sarah Shabot

Donald Prough



▪ INTRODUCTION

This chapter addresses several key questions related to intravenous fluid therapy during anesthesia and surgery:



  • Why do surgical patients require intravenous access?


  • What are the complications of fluid therapy?


  • What fluids are available for use during anesthesia?


  • How much fluid should be given during anesthesia and surgery?


  • How do anesthesiologists monitor fluid therapy?


▪ WHY DO SURGICAL PATIENTS REQUIRE INTRAVENOUS ACCESS?

Nearly all patients who require anesthesia for a surgical or diagnostic procedure must have intravenous access and most also require intravenous fluid therapy. Intravenous access (a “lifeline”) is necessary in the event that emergency drugs are required. Because the volumes and types of intravenous fluids that are administered can cause complications, it is appropriate to consider administration of intravenous fluids as equivalent to the administration of drugs.

Intravenous fluids are necessary to replace preexisting fluid deficits and ongoing losses of blood and fluid. During the perioperative period, a patient’s intravascular volume is in flux. Before scheduled surgical procedures, patients are asked to abstain from oral intake for 6-8 hours to permit their stomachs to empty. This decreases the risk of regurgitation or vomiting of gastric contents and aspiration of those contents into the lungs. Often, with case delays and rearrangement of the surgical schedule, patients are NPO (nil per os— “nothing by mouth”) for greater than 12 hours. Patients who receive no oral intake gradually lose both water and electrolytes, such as sodium and potassium (Table 22.1). In patients who are not able to take in oral food and water, replacement of those losses is referred to as maintenance fluid replacement.


▪ WHAT ARE THE COMPLICATIONS OF FLUID THERAPY?

Complications associated with perioperative fluid therapy can be relatively minor or life threatening. Certainly, the complications that are most important are those that are life threatening, such as shock or pulmonary edema. However, from a patient’s perspective, even short-term symptoms can be quite distressing. Complications can arise from inadequate fluid administration or excessive administration:



  • Risks of inadequate fluid administration



    • Life-threatening



      • Lactic acidosis (shock)


      • Acute renal failure


      • Multisystem organ failure


    • Non-life-threatening



      • Thirst


      • Drowsiness


      • Dizziness


      • Postoperative nausea and vomiting


      • Pain


  • Risks of excessive fluid administration



    • Life-threatening



      • Pulmonary edema


      • Cardiac failure


    • Less life-threatening



      • Obvious link or outcomes to fluid administration


      • Peripheral edema


      • Periorbital edema


    • Not-so-obvious link



      • Impaired gut function


      • Impaired wound healing









TABLE 22.1 CALCULATION OF MAINTENANCE REQUIREMENTS FOR WATER, SODIUM AND POTASSIUM















Water: 2,500 mL/d/70 kg


1. 4:2:1 rule—4 mL/kg/hr for the first 10 kg of body weight, 2 mL/kg/hr for the second 10 kg of body weight, and 1 mL/kg/hr for all additional kilograms of body weight



2. 100:50:20 rule—100 mL/kg/d for the first 10 kg of body weight, 50 mL/kg/d for the second 10 kg of body weight, and 20 mL/kg/d for all additional kilograms of body weight


Sodium (Na+)


1.0 mEq/kg/d (70 mEq/2,500 mL or approximately 28 mEq/L)


Potassium (K+)


0.75 mEq/kg/d (50 mEq/2,500 mL or approximately 20 mEq/L)



▪ WHAT FLUIDS ARE AVAILABLE FOR USE DURING ANESTHESIA?

Intravenous fluids are classified as either crystalloid or colloid solutions. A crystalloid solution is an aqueous solution of low-molecular-weight salts, such as sodium chloride (table salt). Crystalloid solutions quickly escape blood vessels and equilibrate with extravascular, extracellular fluid, so only a small fraction of infused crystalloid produces sustained expansion of plasma volume. In contrast, colloid solutions are high-molecular-weight substances, such as large proteins or large complex sugars, suspended in crystalloid solutions. Because of these large molecules, colloid solutions remain inside of blood vessels and maintain plasma volume more effectively than crystalloid solutions.

No strong clinical evidence establishes the superiority of either crystalloids or colloids. Both colloid and crystalloid solutions can be used effectively for fluid resuscitation. A large clinical trial in critically ill patients recently failed to identify any effect of the choice of colloid or crystalloid on mortality.


Crystalloid Solutions

Crystalloids are generally considered the primary resuscitation fluid. The most commonly used crystalloid solutions are 0.9% saline (often colloquially and incorrectly called “normal” saline) and lactated Ringer’s solution, a balanced salt solution that contains small amounts of electrolytes other than sodium and chloride (Table 22.2). The anesthesiologist must consider the varying constituents of each solution when planning intravenous fluid therapy. For example, administering large volumes of 0.9% saline can lead to increased serum chloride levels and produce a metabolic acidosis. Alternatively, infusing large amounts of lactated Ringer’s solution can produce the opposite, a metabolic alkalosis, as the lactate in the solution is metabolized to bicarbonate. The provider must also consider the potassium content in the solution. Many patients present to the operating room with an increased baseline potassium level, and increasing it further could be hazardous. Of note, the presence of calcium in lactated Ringer’s solution prohibits its use as a “carrier” solution when administering citrated blood products. The reaction of citrate and calcium will cause red cells to aggregate.

While glucose can be added to intravenous solutions, such mixtures are usually avoided during the perioperative period. Increased serum glucose levels can lead to several unwanted
complications. Unless a patient is at risk for intraoperative hypoglycemia, glucose-containing solutions are not used. These solutions are reserved for long-term maintenance in hospitalized patients who are NPO for various reasons.








TABLE 22.2 CONTENTS OF CYSTALLOID SOLUTIONS









































Only gold members can continue reading. Log In or Register to continue

May 23, 2016 | Posted by in ANESTHESIA | Comments Off on Fluid Therapy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access


SODIUM (mEq/L)


CHLORIDE (mEq/L)


POTASSIUM (mEq/L)


CALCIUM (mEq/L)


LACTATE (mEq/L)


PH


Extracellular fluid


140


108


4.5


2.0


5.0


7.3


0.9% Saline


154


154





5.6


Lactated Ringer’s solution


130


109


4.0


3.0


28


6.6


Plasma-Lyte


140


98


5.0